Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956272721> ?p ?o ?g. }
- W2956272721 endingPage "104563" @default.
- W2956272721 startingPage "104563" @default.
- W2956272721 abstract "Feline herpesvirus type 1 (FHV-1) and feline calicivirus (FCV) are considered as main causes of feline upper respiratory tract disease and the most common clinical manifestations include rhinotracheitis, conjunctivitis, and nasal/facial ulcerations. While the primary infection is relatively mild, secondary infections pose a threat to young or immunocompromised cats and may result in a fatal outcome. In this study, we made an effort to evaluate antiviral potency of poly(sodium 4-styrenesulfonates) (PSSNa) as potent FHV-1 and FCV inhibitors for topical use. Mechanistic studies showed that PSSNa exhibits a different mechanism of action depending on target species. While PSSNa acts directly on FHV-1 particles blocking their interaction with the host's cell and preventing the infection, the antiviral potency against FCV is based on inhibition at late stages of the viral replication cycle. Altogether, PSSNa polymers are promising drug candidates to be used in the treatment and prevention of the viral upper respiratory tract disease (URTD), regardless of the cause." @default.
- W2956272721 created "2019-07-23" @default.
- W2956272721 creator A5002818147 @default.
- W2956272721 creator A5004106523 @default.
- W2956272721 creator A5012190007 @default.
- W2956272721 creator A5014080056 @default.
- W2956272721 creator A5034854162 @default.
- W2956272721 creator A5048627688 @default.
- W2956272721 creator A5049473577 @default.
- W2956272721 creator A5053008054 @default.
- W2956272721 creator A5056483519 @default.
- W2956272721 creator A5066890613 @default.
- W2956272721 creator A5068761693 @default.
- W2956272721 creator A5069633451 @default.
- W2956272721 creator A5072862893 @default.
- W2956272721 creator A5073292040 @default.
- W2956272721 date "2019-10-01" @default.
- W2956272721 modified "2023-10-12" @default.
- W2956272721 title "Cat flu: Broad spectrum polymeric antivirals" @default.
- W2956272721 cites W1058635922 @default.
- W2956272721 cites W148895522 @default.
- W2956272721 cites W1564276704 @default.
- W2956272721 cites W1580979140 @default.
- W2956272721 cites W1975733629 @default.
- W2956272721 cites W1979546393 @default.
- W2956272721 cites W1985696838 @default.
- W2956272721 cites W1986812169 @default.
- W2956272721 cites W1988839199 @default.
- W2956272721 cites W1989417999 @default.
- W2956272721 cites W1994636219 @default.
- W2956272721 cites W1998643471 @default.
- W2956272721 cites W2002398214 @default.
- W2956272721 cites W2009860627 @default.
- W2956272721 cites W2013433254 @default.
- W2956272721 cites W2018340263 @default.
- W2956272721 cites W2033676113 @default.
- W2956272721 cites W2049840447 @default.
- W2956272721 cites W2051865862 @default.
- W2956272721 cites W2055594999 @default.
- W2956272721 cites W2057462889 @default.
- W2956272721 cites W2069094887 @default.
- W2956272721 cites W2071803370 @default.
- W2956272721 cites W2074684666 @default.
- W2956272721 cites W2076258503 @default.
- W2956272721 cites W2080258959 @default.
- W2956272721 cites W2081502882 @default.
- W2956272721 cites W2088046841 @default.
- W2956272721 cites W2101653169 @default.
- W2956272721 cites W2102255881 @default.
- W2956272721 cites W2104815595 @default.
- W2956272721 cites W2105014080 @default.
- W2956272721 cites W2106306975 @default.
- W2956272721 cites W2111773881 @default.
- W2956272721 cites W2121256227 @default.
- W2956272721 cites W2128224464 @default.
- W2956272721 cites W2131765618 @default.
- W2956272721 cites W2140546048 @default.
- W2956272721 cites W2143443672 @default.
- W2956272721 cites W2151110279 @default.
- W2956272721 cites W2152415449 @default.
- W2956272721 cites W2154941069 @default.
- W2956272721 cites W2256756668 @default.
- W2956272721 cites W2287991835 @default.
- W2956272721 cites W2313182188 @default.
- W2956272721 cites W2758251544 @default.
- W2956272721 cites W2772365493 @default.
- W2956272721 cites W2887703532 @default.
- W2956272721 cites W2959469133 @default.
- W2956272721 cites W4240266822 @default.
- W2956272721 cites W4240504763 @default.
- W2956272721 doi "https://doi.org/10.1016/j.antiviral.2019.104563" @default.
- W2956272721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31325462" @default.
- W2956272721 hasPublicationYear "2019" @default.
- W2956272721 type Work @default.
- W2956272721 sameAs 2956272721 @default.
- W2956272721 citedByCount "10" @default.
- W2956272721 countsByYear W29562727212020 @default.
- W2956272721 countsByYear W29562727212021 @default.
- W2956272721 countsByYear W29562727212022 @default.
- W2956272721 countsByYear W29562727212023 @default.
- W2956272721 crossrefType "journal-article" @default.
- W2956272721 hasAuthorship W2956272721A5002818147 @default.
- W2956272721 hasAuthorship W2956272721A5004106523 @default.
- W2956272721 hasAuthorship W2956272721A5012190007 @default.
- W2956272721 hasAuthorship W2956272721A5014080056 @default.
- W2956272721 hasAuthorship W2956272721A5034854162 @default.
- W2956272721 hasAuthorship W2956272721A5048627688 @default.
- W2956272721 hasAuthorship W2956272721A5049473577 @default.
- W2956272721 hasAuthorship W2956272721A5053008054 @default.
- W2956272721 hasAuthorship W2956272721A5056483519 @default.
- W2956272721 hasAuthorship W2956272721A5066890613 @default.
- W2956272721 hasAuthorship W2956272721A5068761693 @default.
- W2956272721 hasAuthorship W2956272721A5069633451 @default.
- W2956272721 hasAuthorship W2956272721A5072862893 @default.
- W2956272721 hasAuthorship W2956272721A5073292040 @default.
- W2956272721 hasConcept C126322002 @default.
- W2956272721 hasConcept C140704245 @default.
- W2956272721 hasConcept C159047783 @default.